Skip to main content
. 2015 Aug 26;7(9):3424–3435. doi: 10.3390/toxins7093424

Table 1.

Clinical and demographic features of patients with multiple sclerosis.

Patients Sex (M/F) Age (Years) Disease Duration (Years) MS Subtypes EDSS MRI Spinal Lesion Localization
1 F 44 15 RR 2.5 C4-C6
2 F 41 15 RR 3.5 C5-C7
3 F 57 38 SP 6.5 C4-C5, D6-D9
4 F 56 16 RR 3.0 C3-C4, C4-C5, C5-C6, C7
5 M 45 18 RR 3.5 C4, D6-D7
6 F 37 14 RR 3.0 C3-C5
7 F 39 21 RR 4.0 C4-C6, D5-D6
8 F 51 29 RR 4.0 C3-C4, D3, D6
9 F 36 14 RR 2.5 C7-D1, D6, D7
10 F 47 15 SP 6.0 C2, C5, C7
11 F 46 24 RR 2.5 C3, D2-D3
12 M 54 38 RR 5.0 C2-C3, C6, D4
13 M 43 5 RR 2.5 C2, D4, D7, D9
14 M 33 10 RR 4.0 C2-C3, C4-C5, C6, D3
15 F 57 16 RR 2.5 C5
16 F 47 20 RR 6.0 C3, C6, D2-D4
17 M 58 31 SP 6.5 C2-C3, D6-D8
18 F 26 7 RR 3.0 C4-C5, D3, D4
19 F 49 14 SP 6.0 C4-C6
20 M 27 9 RR 1.0 D9-L1
21 F 32 14 RR 1.0 C4, D2, D6
22 F 54 17 RR 4.5 C2-C3, C6-C7, D6, D7
23 F 35 7 RR 2.5 C3, C6, D4
24 F 60 30 RR 4.0 C1-C2, D5, D9
25 F 30 8 RR 2.5 C5, C7, D6
Mean ± SE 6M, 19F 44.1 ± 2 17.8 ± 2 - 3.7 ± 0.3 -

EDSS: Kurtzke’s Expanded Disability Status Scale; MRI: magnetic resonance imaging; MS multiple sclerosis; RR relapsing-remitting; SP secondary progressive.